Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 164 publications
Beyond Cell Cycle Control: CDKN2A Loss Orchestrates NAD + Metabolic Plasticity and NAMPT Inhibitor Sensitivity in Glioblastoma.
Journal: bioRxiv : the preprint server for biology
Published: January 23, 2026
Clinical and radiographic prognostic factors in recurrent contrast-enhancing IDH-mutant gliomas treated with bevacizumab.
Journal: Neuro-oncology advances
Published: December 29, 2025
Beyond cell cycle control: CDKN2A loss is associated with altered NAD+ metabolic states and increased sensitivity to NAMPT inhibition in glioblastoma.
Journal: Neuro-oncology advances
Published: December 09, 2025
MGMT downregulation by CRISPR/Cas13 RNA-guided RNA targeting enhances glioma cell sensitivity to TMZ chemotherapy.
Journal: Journal of neuro-oncology
Published: November 01, 2025
A multifocal IDH-mutant glioma with differential response to IDH inhibition: Role of quantitative neuroimaging.
Journal: Radiology case reports
Published: October 27, 2025
Perfusion, diffusion, and anatomical MRI characteristics of pathologically confirmed malignant transformation in IDH-mutant gliomas.
Journal: Neuro-oncology
Published: September 01, 2025
A single-institution retrospective study of multicentric gliomas stratified by IDH mutational status.
Journal: Neuro-oncology advances
Published: August 14, 2025
Computed tomography versus radiography for assessment of canine humeral condylar fracture malreductions.
Journal: New Zealand veterinary journal
Published: August 10, 2025
Publisher Correction: Valproic acid targets IDH1 mutants through alteration of lipid metabolism.
Journal: npj metabolic health and disease
Published: July 03, 2025
A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma.
Journal: Neuro-oncology advances
Published: March 07, 2025
Last Updated: 09/26/2026